Mark Tullos, MD
Surgery · Victoria, TXNPI 1952365207
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,650 of the $5,244 with a category attached, or 69.6%. Endogastric Solutions, Inc accounts for 85.9% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $4,498 and has fallen 96.1% since, to $174 in 2025.
Across 33 payments — averaging $158.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endogastric Solutions, Inc$5K
- Medtronic$194
- TELA Bio, Inc.$137
- Alafair Biosciences, Inc.$99
- Integra Lifesciences Corporation$43
- Davol Inc.$34
- plus $236 from 10 others
What the payments were for
- Consulting fees$3,65070%
- Travel & lodging$78515%
- Food & beverage$80915%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endogastric Solutions, Inc | 4 | $4,502 |
| Medtronic | 7 | $194 |
| TELA Bio, Inc. | 6 | $137 |
| Alafair Biosciences, Inc. | 2 | $99 |
| Integra Lifesciences Corporation | 1 | $43 |
| Davol Inc. | 2 | $34 |
| Innocoll Pharmaceuticals Limited | 2 | $32 |
| Johnson & Johnson | 1 | $31 |
| KCI USA, Inc. | 1 | $31 |
| Exact Sciences | 1 | $30 |
| Dilon Technologies, Inc. | 1 | $23 |
| Teleflex LLC | 1 | $22 |
| Organogenesis Inc. | 1 | $21 |
| AstraZeneca | 1 | $18 |
| Capsovision, Inc. | 1 | $16 |
| Cook Medical LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ESOPHYX$4,435
How this compares
$5,244 in reported general payments places this provider in the 60th percentile of 1,830 surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 39 | $226 |
| Tramadol Hcl | 28 | $52 |
Paid to pharmacies, not to this prescriber.
Other surgery in Victoria
- Michael HarkinsTomball$2.7M
- Douglas StoddardAustin$1.4M
- Steven FassAustin$989K
- Vineet ChoudhryAustin$851K
- Andy HawthorneRound Rock$843K
- Nancy MarquezAustin$700K
- Sachin KukrejaDallas$640K
- Alejandro EsquivelAustin$631K
- Erik WilsonBellaire$610K
- Folahan AyoolaDenton$570K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.